商业-话题@MedSci

#商业#

128篇内容 | 2936人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1771750, encodeId=d25f1e7175046, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=Exp Parasitol.：两种商业性常用于降低眼压的眼药水具有抗棘阿米巴原虫活性！, objectType=article, longId=108322, objectId=21b210832265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21b210832265, replyNumber=0, likeNumber=68, createdTime=2017-11-29, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21b210832265, moduleTitle=Exp Parasitol.：两种商业性常用于降低眼压的眼药水具有抗棘阿米巴原虫活性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21b210832265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771764, encodeId=83b11e71764e4, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=CCLM：纤维蛋白原测定：国际和商业标准和质控样本的可交换性评估, objectType=article, longId=118274, objectId=c5901182e42a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5901182e42a, replyNumber=0, likeNumber=74, createdTime=2018-01-21, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5901182e42a, moduleTitle=CCLM：纤维蛋白原测定：国际和商业标准和质控样本的可交换性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5901182e42a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771737, encodeId=52871e717377b, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=医药商业的出路：成为大型药企的区域营销机构, objectType=article, longId=99081, objectId=32fe99081e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32fe99081e5, replyNumber=0, likeNumber=63, createdTime=2018-03-13, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32fe99081e5, moduleTitle=医药商业的出路：成为大型药企的区域营销机构, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32fe99081e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771753, encodeId=ee361e71753b3, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=新加坡政府大力支持Lion TCR生物公司产品的国际商业化, objectType=article, longId=111385, objectId=6cb611138583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb611138583, replyNumber=0, likeNumber=86, createdTime=2018-07-25, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb611138583, moduleTitle=新加坡政府大力支持Lion TCR生物公司产品的国际商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb611138583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771749, encodeId=ff131e71749a1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=为何医学直播的商业价值没有那么大？, objectType=article, longId=108089, objectId=8b35108089b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b35108089b0, replyNumber=0, likeNumber=58, createdTime=2018-02-05, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b35108089b0, moduleTitle=为何医学直播的商业价值没有那么大？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b35108089b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771748, encodeId=f0d91e7174815, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=医疗AI技术火热，但其商业模式的落脚点究竟在哪？, objectType=article, longId=106971, objectId=d50d1069e19b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d50d1069e19b, replyNumber=0, likeNumber=70, createdTime=2018-05-16, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d50d1069e19b, moduleTitle=医疗AI技术火热，但其商业模式的落脚点究竟在哪？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d50d1069e19b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771761, encodeId=64fa1e717618b, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=《中国商业健康保险研究报告》发布预测“淘金”领域, objectType=article, longId=114392, objectId=86551143926f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86551143926f, replyNumber=0, likeNumber=52, createdTime=2018-03-04, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86551143926f, moduleTitle=《中国商业健康保险研究报告》发布预测“淘金”领域, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86551143926f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771759, encodeId=8bed1e7175909, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=医药商业企业转型成功的前提, objectType=article, longId=112841, objectId=db4a11284127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db4a11284127, replyNumber=0, likeNumber=55, createdTime=2017-11-24, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db4a11284127, moduleTitle=医药商业企业转型成功的前提, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db4a11284127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771767, encodeId=23f11e7176714, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=Circ Cardiovasc Qual Outcomes：3种非专利降压药商业化对不良事件有何影响？, objectType=article, longId=120812, objectId=463112081258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=463112081258, replyNumber=0, likeNumber=65, createdTime=2018-10-24, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=463112081258, moduleTitle=Circ Cardiovasc Qual Outcomes：3种非专利降压药商业化对不良事件有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=463112081258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771754, encodeId=111c1e71754f8, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=联合构建区域新型商业集团公司, objectType=article, longId=112041, objectId=24b61120418a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24b61120418a, replyNumber=0, likeNumber=70, createdTime=2018-06-29, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24b61120418a, moduleTitle=联合构建区域新型商业集团公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24b61120418a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771725, encodeId=dbd81e71725c4, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=2017年全国血腥并购大幕拉开！五大医药商业公司PK业绩, objectType=article, longId=93121, objectId=c8a5931215e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8a5931215e, replyNumber=0, likeNumber=43, createdTime=2017-09-12, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8a5931215e, moduleTitle=2017年全国血腥并购大幕拉开！五大医药商业公司PK业绩, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8a5931215e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771744, encodeId=70e31e717443c, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=顾昕：医保政策未定医生集团应紧抱商业健康保险, objectType=article, longId=103682, objectId=3637103682e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3637103682e5, replyNumber=0, likeNumber=78, createdTime=2018-01-26, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3637103682e5, moduleTitle=顾昕：医保政策未定医生集团应紧抱商业健康保险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3637103682e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771726, encodeId=4f2b1e7172619, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=不同商业企业生存和发展的思考, objectType=article, longId=96405, objectId=6ba49640507, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba49640507, replyNumber=0, likeNumber=74, createdTime=2018-03-09, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba49640507, moduleTitle=不同商业企业生存和发展的思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba49640507)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771731, encodeId=05561e71731eb, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=医药商业企业四大转型方向（上篇）, objectType=article, longId=97343, objectId=46179e343a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46179e343a8, replyNumber=0, likeNumber=56, createdTime=2017-05-05, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46179e343a8, moduleTitle=医药商业企业四大转型方向（上篇）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46179e343a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771747, encodeId=900b1e7174758, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=合全药业与TESARO公司签署全球商业化供应协议, objectType=article, longId=106644, objectId=80f5106644c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80f5106644c0, replyNumber=0, likeNumber=51, createdTime=2018-05-06, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80f5106644c0, moduleTitle=合全药业与TESARO公司签署全球商业化供应协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80f5106644c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771735, encodeId=3d991e717351c, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=中小医药商业的出路：区域终端和基层医药市场, objectType=article, longId=98507, objectId=fb149850ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb149850ed9, replyNumber=0, likeNumber=70, createdTime=2017-06-22, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb149850ed9, moduleTitle=中小医药商业的出路：区域终端和基层医药市场, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb149850ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771752, encodeId=2c061e71752af, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=构建新营销体系的核心是商业模式, objectType=article, longId=110551, objectId=3199110551f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3199110551f6, replyNumber=0, likeNumber=83, createdTime=2018-03-03, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3199110551f6, moduleTitle=构建新营销体系的核心是商业模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3199110551f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771723, encodeId=70b51e7172340, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=影响医药商业机构变革的几大模式, objectType=article, longId=92707, objectId=bd0292e077b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd0292e077b, replyNumber=0, likeNumber=60, createdTime=2017-07-18, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd0292e077b, moduleTitle=影响医药商业机构变革的几大模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd0292e077b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771760, encodeId=e9791e7176011, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=一文透视30家Medical Mall商业模式, objectType=article, longId=113282, objectId=1e9711328289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e9711328289, replyNumber=0, likeNumber=58, createdTime=2018-03-28, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e9711328289, moduleTitle=一文透视30家Medical Mall商业模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e9711328289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771717, encodeId=607b1e71717d0, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=上海：明年起职工医保个人账户可购买商业保险, objectType=article, longId=85811, objectId=4409858114d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4409858114d, replyNumber=0, likeNumber=86, createdTime=2017-05-03, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4409858114d, moduleTitle=上海：明年起职工医保个人账户可购买商业保险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4409858114d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

商业

2020-05-29

zhangxingru (审核中...)

前往app查看评论内容

#商业#

Exp Parasitol.：两种商业性常用于降低眼压的眼药水具有抗棘阿米巴原虫活性！

2017-11-29

zhangxingru (审核中...)

前往app查看评论内容

#商业#

CCLM：纤维蛋白原测定：国际和商业标准和质控样本的可交换性评估

2018-01-21

zhangxingru (审核中...)

前往app查看评论内容

#商业#

医药商业的出路：成为大型药企的区域营销机构

2018-03-13

zhangxingru (审核中...)

前往app查看评论内容

#商业#

新加坡政府大力支持Lion TCR生物公司产品的国际商业化

2018-07-25

zhangxingru (审核中...)

前往app查看评论内容

#商业#

为何医学直播的商业价值没有那么大？

2018-02-05

zhangxingru (审核中...)

前往app查看评论内容

#商业#

医疗AI技术火热，但其商业模式的落脚点究竟在哪？

2018-05-16

zhangxingru (审核中...)

前往app查看评论内容

#商业#

《中国商业健康保险研究报告》发布预测“淘金”领域

2018-03-04

zhangxingru (审核中...)

前往app查看评论内容

#商业#

医药商业企业转型成功的前提

2017-11-24

zhangxingru (审核中...)

前往app查看评论内容

#商业#

Circ Cardiovasc Qual Outcomes：3种非专利降压药商业化对不良事件有何影响？

2018-10-24

zhangxingru (审核中...)

前往app查看评论内容

#商业#

联合构建区域新型商业集团公司

2018-06-29

zhangxingru (审核中...)

前往app查看评论内容

#商业#

2017年全国血腥并购大幕拉开！五大医药商业公司PK业绩

2017-09-12

zhangxingru (审核中...)

前往app查看评论内容

#商业#

顾昕：医保政策未定医生集团应紧抱商业健康保险

2018-01-26

zhangxingru (审核中...)

前往app查看评论内容

#商业#

不同商业企业生存和发展的思考

2018-03-09

zhangxingru (审核中...)

前往app查看评论内容

#商业#

医药商业企业四大转型方向（上篇）

2017-05-05

zhangxingru (审核中...)

前往app查看评论内容

#商业#

合全药业与TESARO公司签署全球商业化供应协议

2018-05-06

zhangxingru (审核中...)

前往app查看评论内容

#商业#

中小医药商业的出路：区域终端和基层医药市场

2017-06-22

zhangxingru (审核中...)

前往app查看评论内容

#商业#

构建新营销体系的核心是商业模式

2018-03-03

zhangxingru (审核中...)

前往app查看评论内容

#商业#

影响医药商业机构变革的几大模式

2017-07-18

zhangxingru (审核中...)

前往app查看评论内容

#商业#

一文透视30家Medical Mall商业模式

2018-03-28

zhangxingru (审核中...)

前往app查看评论内容

#商业#

上海：明年起职工医保个人账户可购买商业保险

2017-05-03

科室
- - 订阅+
  - 更多科室
工具
服务